New Tool: ProSource
Checkout our packaging and processing solutions finder, ProSource.
Start Your Search

October 2010 Safety Labeling Changes: 34 Medical Product Labels with changes to Boxed Warnings, Contraindications, Precautions, Adverse Reactions

The MedWatch October 2010 Safety Labeling Changes posting includes 34 products with safety labeling changes to the following sections: BOXED WARNINGS, CONTRAINDICATIONS, WARNINGS, PRECAUTIONS, ADVERSE REACTIONS, PATIENT PACKAGE INSERT, and MEDICATION GUIDE.

The "Summary Page" provides a listing of drug names and safety labeling sections revised:

Clicking on a drug product name in the Summary View will take you to the "detailed view" page, which identifies safety labeling sections and subsections revised, along with a brief summary of new or modified safety information.

The following drugs had modifications to the BOXED WARNINGS, CONTRAINDICATIONS and WARNINGS sections:

Aldara (imiquimod)
Altace (ramipril)
Depo-Provera Contraceptive injection (medroxyprogesterone acetate)
Enablex (darifenacin)
Fragmin (dalteparin sodium)
Gris-PEG (griseofulvin ultramicrosized)
Invirase (saquinavir mesylate)
Lamictal (lamotrigine)
Lasix (furosemide)
Letairis (ambrisentan)
Myfortic(mycophenolic acid)
Nexavar (sorafenib tosylate)
Nuvigil (armodafinil)
Precedex (dexmedetomidine hydrochloride)
Procardia XL (nifedipine)
Provigil (modafinil)
Rebetol (ribavirin)
Rythmol SR (propafenone hydrochloride) extended-release capsules
Sprycel (dasatinib)
Test Your Supply Chain Smarts
Take Healthcare Packaging's supply chain quiz to prove your knowledge!
Take Quiz
Test Your Supply Chain Smarts
Discover Our Content Hub
Access Healthcare Packaging's free educational content library!
Unlock Learning Here
Discover Our Content Hub